Stay updated on Granix Disruption in Myeloma Transplant Clinical Trial
Sign up to get notified when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.

Latest updates to the Granix Disruption in Myeloma Transplant Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%
- Check17 days agoChange DetectedUpdate to include MedlinePlus Genetics topic on Multiple myeloma and bump to v3.1.0; remove the older term Plasma cell myeloma and revert to v3.1.0 terminology.SummaryDifference0.6%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdds version tag v3.0.2 and removes a related topic (Multiple myeloma), the previous revision v3.0.1, and a Back to Top link; overall, only minor metadata changes with no core-content impact.SummaryDifference0.5%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location in St. Louis, Missouri, along with new content related to plasma cell myeloma and various biological factors. Notably, several previous terms and references related to stem cells and specific drugs have been removed.SummaryDifference5%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Granix Disruption in Myeloma Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.